Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Malignant Lymphoma

  Free Subscription


26.12.2011

2 Am J Clin Pathol
2 Am J Hematol
3 Blood
2 Br J Haematol
4 Cancer
3 Haematologica
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
6 J Clin Oncol
2 J Natl Cancer Inst
7 Leuk Lymphoma
2 Leukemia


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. ZARE H , Bashashati A, Kridel R, Aghaeepour N, et al
    Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma.
    Am J Clin Pathol. 2012;137:75-85.
    PubMed     Text format     Related articles    Abstract available


  2. RYAN RJ , Sloan JM, Collins AB, Mansouri J, et al
    Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with amyloid deposition: a clinicopathologic case series.
    Am J Clin Pathol. 2012;137:51-64.
    PubMed     Text format     Related articles    Abstract available



    Am J Hematol

  3. RAMAKRISHNAN V , Timm M, Haug JL, Kimlinger TK, et al
    Sorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.
    Am J Hematol. 2011 Nov 23. doi: 10.1002/ajh.22263.
    PubMed     Text format     Related articles    Abstract available


  4. STEPHEN S , Morrissey KA, Benoit BM, Kim EJ, et al
    Inhibition of cell-mediated immunity by the histone deacetylase inhibitor vorinostat: Implications for therapy of cutaneous T-cell lymphoma.
    Am J Hematol. 2011 Oct 23. doi: 10.1002/ajh.22231.
    PubMed     Text format     Related articles   



    Blood

  5. O'CALLAGHAN K , Lee L, Nguyen N, Hsieh MY, et al
    Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available


  6. MOSKOWITZ CH , Matasar MJ, Zelenetz AD, Nimer SD, et al
    Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available


  7. CALPE E , Codony C, Baptista MJ, Abrisqueta P, et al
    ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation.
    Blood. 2011;118:4401-10.
    PubMed     Text format     Related articles    Abstract available



    Br J Haematol

  8. AI WZ , Chang ET, Fish K, Fu K, et al
    Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study.
    Br J Haematol. 2011 Dec 20. doi: 10.1111/j.1365-2141.2011.08982.
    PubMed     Text format     Related articles    Abstract available


  9. KELLY KM
    Management of children with high-risk Hodgkin lymphoma.
    Br J Haematol. 2011 Dec 20. doi: 10.1111/j.1365-2141.2011.08975.
    PubMed     Text format     Related articles    Abstract available



    Cancer

  10. MATO AR , Svoboda J, Feldman T, Zielonka T, et al
    Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26731.
    PubMed     Text format     Related articles    Abstract available


  11. BARTA SK , Lee JY, Kaplan LD, Noy A, et al
    Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26723.
    PubMed     Text format     Related articles    Abstract available


  12. RAIZER JJ , Rademaker A, Evens AM, Rice L, et al
    Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26709.
    PubMed     Text format     Related articles    Abstract available


  13. FERRARIO A , Pulsoni A, Olivero B, Rossi G, et al
    Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: Phase 2 study of the Italian Lymphoma Foundation.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26708.
    PubMed     Text format     Related articles    Abstract available



    Haematologica

  14. VILLA D , Seshadri T, Puig N, Massey C, et al
    Second line salvage chemotherapy for transplant-eligible patients with Hodgkin lymphoma resistant to platinum-containing first-line salvage chemotherapy.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available


  15. XU C , Plattel W, van den Berg A, Ruther N, et al
    Expression of the c-Met oncogene by tumor cells predicts favorable outcome in classical Hodgkin lymphoma.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available


  16. JONAK C , Troch M, Kiesewetter B, Lukas J, et al
    Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT-lymphoma).
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available



    Int J Cancer

  17. LOUGHRAN ST , Campion EM, D'Souza BN, Smith SM, et al
    Bfl-1 is a crucial pro-survival nuclear factor-kappaB target gene in Hodgkin/Reed-Sternberg cells.
    Int J Cancer. 2011;129:2787-96.
    PubMed     Text format     Related articles    Abstract available



    Int J Radiat Oncol Biol Phys

  18. WANG J , Shi M
    Response to "Role of FDG-PET in the Definition and Management of Involved-Field Radiation Therapy for Pediatric Hodgkin's Lymphoma."Int J Radiat Oncol Biol Phys (2011;80:324-332).
    Int J Radiat Oncol Biol Phys. 2012;82:494.
    PubMed     Text format     Related articles   



    J Clin Oncol

  19. WANNESSON L , Chigrinova E
    Concordant and Discordant Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma: Are They Understudied Phenomena?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   


  20. VAN GAAL JC , Flucke UE, Roeffen MH, de Bont ES, et al
    Anaplastic Lymphoma Kinase Aberrations in Rhabdomyosarcoma: Clinical and Prognostic Implications.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available


  21. HURE MC , Elco CP, Ward D, Hutchinson L, et al
    Histiocytic Sarcoma Arising From Clonally Related Mantle Cell Lymphoma.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   


  22. VAN DER KAAIJ MA , Heutte N, Meijnders P, Abeilard-Lemoisson E, et al
    Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available


  23. REBHOLZ CE , Reulen RC, Toogood AA, Frobisher C, et al
    Health care use of long-term survivors of childhood cancer: the British Childhood Cancer Survivor Study.
    J Clin Oncol. 2011;29:4181-8.
    PubMed     Text format     Related articles    Abstract available


  24. BANERJEE D , Gascoyne RD, Slack G, Hayes M, et al
    Clinical impact of pathology reviews of outside material: a patient-focused approach.
    J Clin Oncol. 2011;29:4212-3.
    PubMed     Text format     Related articles   



    J Natl Cancer Inst

  25. AL KHABORI M , de Almeida JR, Guyatt GH, Kuruvilla J, et al
    Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis.
    J Natl Cancer Inst. 2011.
    PubMed     Text format     Related articles    Abstract available


  26. JACOBSON CA , Longo DL
    Follicular Lymphoma: To Treat or Not to Treat Is No Longer the Question.
    J Natl Cancer Inst. 2011.
    PubMed     Text format     Related articles   



    Leuk Lymphoma

  27. LOPEZ-GUILLERMO A , Caballero D, Canales M, Provencio M, et al
    Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphoma.
    Leuk Lymphoma. 2011;52 Suppl 3:1-14.
    PubMed     Text format     Related articles    Abstract available


  28. WARSCH S , Hosein PJ, Maeda LS, Alizadeh AA, et al
    A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available


  29. GUISADO-VASCO P , Arranz R, Canales M, Canovas A, et al
    Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score (IPS) for the outcome of advanced Hodgkin Lymphoma in the Spanish Hodgkin Lymphoma Study Group series.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available


  30. ROSKO A , Lazarus HM
    Salvage chemotherapy and autologous hematopoietic cell transplantation (AHCT) in primary refractory diffuse large B-cell lymphoma (DLBCL): Progress or better patient selection?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   


  31. BASAK GW , Mikala G, Koristek Z, Jaksic O, et al
    Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available


  32. PERRY AM , Molina-Kirsch H, Nathwani BN, Diebold J, et al
    Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system.
    Leuk Lymphoma. 2011;52:1681-8.
    PubMed     Text format     Related articles    Abstract available


  33. AL-NAWAKIL C , Kosmider O, Stern MH, Manie E, et al
    Leukemic phase of follicular lymphomas: an atypical presentation.
    Leuk Lymphoma. 2011;52:1504-8.
    PubMed     Text format     Related articles    Abstract available



    Leukemia

  34. COCCO C , Di Carlo E, Zupo S, Canale S, et al
    Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo.
    Leukemia. 2011 Dec 23. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available


  35. SCHUETZ JM , Johnson NA, Morin RD, Scott DW, et al
    BCL2 mutations in diffuse large B-cell lymphoma.
    Leukemia. 2011 Dec 22. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: